The US state of Massachusetts has passed a law that requires pharmaceutical and medical device makers to report to the state Department of Public Health any payment or gift of over $50 which they make to healthcare professionals, according to PharmaTimes.[...]
Urigen Pharmaceuticals has announced that the US Patent and Trademark Office has issued the first patent for the use of URG101, an investigational, bladder instillation treatment for painful bladder syndrome or interstitial cystitis.[...]
Vion Pharmaceuticals has signed an agreement with the Dutch-Belgian Cooperative Trial Group for Hematology Oncology to conduct a clinical trial of laromustine with standard remission-induction therapy in patients aged 18-65 with previously untreated acute myelogenous leukemia and high-risk myelodysplasia.[...]
Schering-Plough has announced that Asmanex Twisthaler 110mcg is now available in pharmacies nationwide.[...]
Pain Therapeutics and King Pharmaceuticals have presented the final data set of a previously announced pivotal Phase III study of Remoxy, an investigational drug to treat chronic pain.[...]
Nello Martini, director of Italy's medicines agency, Aifa or the Italian Agency for Pharmaceuticals, has been dismissed, following a six-week suspension, according to PharmaTimes.[...]
Lupin has signed a multi-year promotion and marketing agreement for the AeroChamber Plus line of products with Forest Laboratories.[...]
Atritech has filed its pre-market approval application with the FDA. The PMA contains the results of the Protect AF clinical trial which began enrollment in early 2005.[...]
Vical has announced a research collaboration with the Karolinska Institute, a European medical university, and the Swedish Institute for Infectious Disease Control, a governmental expert agency, to evaluate the company's Vaxfectin adjuvant with the Biojector 2000 needle-free injection system for a multivalent preventive DNA vaccine against HIV.[...]
Neurologix has received institutional review board approvals to begin recruiting and enrolling participants for its Phase II clinical trial of the company's gene transfer approach to the treatment of advanced Parkinson's disease.[...]
Benda Pharmaceutical, a provider of traditional Chinese and conventional medicines, has appointed George Zhou as its new COO.[...]
Ziopharm Oncology has received notice from the European Patent Office that it intends to grant a patent with claims covering certain pharmaceutical formulations of indibulin for oral administration and processes for manufacturing such formulations.[...]
Stellar Pharmaceuticals has announced that its US licensee, Watson Pharma, has concluded the first and only placebo controlled study with Uracyst.[...]
Covidien has announced that its Mallinckrodt Baker business has entered into a licensing and commercialization agreement with drug development research specialist Rubicon Research.[...]
BMP Sunstone has announced that the Sunstone Pharmaceutical, its wholly-owned subsidiary, has received a production license from the Chinese State Food and Drug Administration to manufacture and market GoodBaby multivitamin granules, a multivitamin formula for infants and children in China.[...]
Riemser Arzneimittel, a German pharmaceutical company, has purchased the worldwide specialty dental business of Curasan, including its three leading products, Cerasorb, EpiGuide and Revois.[...]
Can-Fite BioPharma has announced that Seikagaku, the exclusive licensee of the company's CF101 in the Japanese market, is about to commence Phase I clinical trial in Japan with CF101 for the treatment of rheumatoid arthritis.[...]
Onyx Pharmaceuticals, a biopharmaceutical company, has appointed Juergen Lasowski as its new senior vice president of corporate development.[...]
US-based biopharmaceutical company Spectrum Pharmaceuticals has launched Fusilev for injection.[...]
AstraZeneca has signed a memorandum of understanding with the National Cancer Centre Singapore and the National University Hospital to develop anti-cancer compounds.[...]
Abbott and AstraZeneca have signed an agreement pursuant to which, Abbott will promote AstraZeneca's Crestor, a medication used along with diet to reduce high cholesterol.[...]
Dusa Pharmaceuticals has signed a non-exclusive patent license agreement granting River's Edge Pharmaceuticals rights for a vitamin-mineral product in the prescription market.[...]
China Sky One Medical, a fully integrated pharmaceutical company producing external use, over-the-counter drugs in the People's Republic of China, has developed a nasal spray for the treatment and prevention of rheumatic disease.[...]
Parexel International, a global biopharmaceutical services organization, has closed the acquisition of ClinPhone, a clinical technology organization.[...]
Topigen Pharmaceuticals, a clinical-stage biopharmaceutical company specialized in developing products for respiratory disorders, has appointed Mark Parry-Billings as its new CEO.[...]
